133 related articles for article (PubMed ID: 7893582)
1. Angiotensin converting enzyme inhibition does not affect the response to exogenous angiotensin II in the human forearm.
Lyons D; Stewart D; Webster J; Benjamin N
Br J Clin Pharmacol; 1994 Nov; 38(5):417-20. PubMed ID: 7893582
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme inhibition does not affect response to exogenous angiotensin II in the forearm of mild-moderate hypertensive patients.
Lyons D; Webster J; Benjamin N
Eur J Clin Pharmacol; 1994; 47(2):147-50. PubMed ID: 7859801
[TBL] [Abstract][Full Text] [Related]
3. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner HR
J Cardiovasc Pharmacol; 1995 Jun; 25(6):986-93. PubMed ID: 7564346
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
[TBL] [Abstract][Full Text] [Related]
6. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
Lyons D; Webster J; Nixon A; Young MM; Smith J; Benjamin N
Br J Clin Pharmacol; 1997 Mar; 43(3):323-6. PubMed ID: 9088589
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
McIntyre M; MacFadyen RJ; Meredith PA; Menard J; Brunner HR; Insuasty J; Reid JL
J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Nussberger J; Wuerzner G; Jensen C; Brunner HR
Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
[TBL] [Abstract][Full Text] [Related]
9. Effect of enalapril and quinapril on forearm vascular ACE in man.
Lyons D; Webster J; Benjamin N
Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
Ferro CJ; Spratt JC; Haynes WG; Webb DJ
Circulation; 1998 Jun; 97(23):2323-30. PubMed ID: 9639376
[TBL] [Abstract][Full Text] [Related]
11. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
Ritter JM; Cockcroft JR; Sciberras DG; Goldberg MR
J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
[TBL] [Abstract][Full Text] [Related]
14. Effects of glibenclamide on blood pressure and cardiovascular responsiveness in non-insulin dependent diabetes mellitus.
Williams S; Abbott D; Morfis L; Manwaring P; Diamond T; Howes LG
J Hypertens; 1998 May; 16(5):705-11. PubMed ID: 9797183
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
16. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
[TBL] [Abstract][Full Text] [Related]
17. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.
Newby DE; Goodfield NE; Flapan AD; Boon NA; Fox KA; Webb DJ
Heart; 1998 Aug; 80(2):134-40. PubMed ID: 9813557
[TBL] [Abstract][Full Text] [Related]
18. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
Hollenberg NK; Fisher ND; Price DA; Williams GH
Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
[TBL] [Abstract][Full Text] [Related]
19. Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man.
Lyons D; Jackson SH; Swift CG
Clin Pharmacol Ther; 2007 Jan; 81(1):83-7. PubMed ID: 17186003
[TBL] [Abstract][Full Text] [Related]
20. The effect of HN-65021 on responses to angiotensin II in human forearm vasculature.
Cockcroft JR; Chowienczyk PJ; Brett SE; Mant TG; Durnin C; Lynn F; Stevenson P; Ritter JM
Br J Clin Pharmacol; 1995 Dec; 40(6):591-3. PubMed ID: 8703667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
